Metformin leads to cell cycle arrest and reduces cell growth, proliferation, protein synthesis and the cancer stem cell number in the tumor and its microenvironment by activating the AMPK pathway and inhibiting the mTOR pathway or PI3K/AKT pathway [12,13,23]. Here, MTOR is linked to neoplasm.